Vodori, a Chicago, IL-based cloud software provider for life science companies, raised $7.5 million in a Series A financing round was led by Baird Capital with participation from select existing investors.
In conjunction with the funding, Jim Pavlik, Partner with Baird Capital’s Venture Capital team, will join the Board of Directors at Vodori, alongside existing Directors Brian Parker, Jim Hussey, Richard Gochnauer, and Scott Rovegno.
The company intends to use the funds to continue to expand operations and its business reach.
Round: Series A
Funding Month: September 2021
Lead Investors: Baird Capital
Company Website: https://www.vodori.com/
Software Category: Content review, sales enablement, and analytics software
About Company: Led by Scott Rovegno, CEO and Co-Founder, Vodori provides Pepper Cloud® Product Suite, which streamlines and automates how life science companies get critical content to key audiences including patients, healthcare providers, and key opinion leaders in life science companies to bring vital drugs, vaccines, medical devices, and diagnostic solutions to market fast. The connected platform modernizes content review, sales, and MSL enablement, and delivers timely analytics to optimize essential processes. The Pepper Cloud Product Suite is used by thousands of life science professionals in more than 50 countries worldwide. Customers represent a variety of pharmaceutical, biotechnology, diagnostic, and medical device companies including Biocartis, Progenity, Tris Pharma and Generate Life Sciences.